Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Upadacitinib effectively treated severe atopic dermatitis, vitiligo, and alopecia areata in one patient.

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

Botulinum toxin A may help regrow hair in pattern baldness.

Marine compounds from gorgonians and soft corals show promise for drug development, especially for chronic disorders.

The new compound may be a safer alternative to finasteride for prostate protection.

Serial trichoscopy is more reliable than the modified hair pull test for tracking alopecia areata.

Alpha-blockers are the most effective and widely used treatment for lower urinary tract symptoms, with minimal side effects.

Combining a GnRH agonist with a low-dose oral contraceptive is more effective and safer for treating hirsutism than using either alone.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

Alfatradiol (0.025%) is an effective and safe treatment for hair loss in both women and men.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

Finasteride reduces hair loss by blocking testosterone's effects on scalp cells.

Tyrosine kinases are important in skin autoimmune diseases and could be targets for new treatments.

Interest in JAK inhibitors for hair loss increased significantly after media coverage and FDA approval.

BTA safely and effectively treats hair loss, and works better with FNS.

Tridax procumbens L. has compounds that can fight fungi.

Osthole inhibits the TRPV3 channel by binding to specific sites, potentially aiding drug development for skin diseases and cancers.

The extract from Bacillus/Trapa japonica fruit helps increase hair growth and could be a potential treatment for hair loss.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

GnRH treatment can reduce breast cancer cell invasion.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

Triamcinolone acetonide helps scalp grafts grow hair successfully.

Ritlecitinib shows promise in improving hair regrowth in adolescents with alopecia areata.

Combining standard treatment with exogenous cholinesterases can improve outcomes in severe organophosphate poisoning.

A new small peptide may help hair growth by activating a specific receptor and should be tested in humans.

Deuruxolitinib effectively promotes hair regrowth in adults with alopecia areata.

Allopregnanolone and opioids together reduce stress hormone responses during pregnancy.

Optimized microneedles promote hair regrowth better than minoxidil without safety risks.

Tadalafil and Finasteride may help treat aggressive melanoma.

The method is quick and effective for testing steroid 5 alpha-reductase inhibitors.